BLISSGVS vs RPGLIFE: Stock Comparison

Bliss GVS Pharma Limited vs RPG Life Sciences Limited

Live data: 2 July 2026, 4:08 PM IST • Source: NSE and company filings

RPG Life Sciences Limited is the larger company by market capitalisation. Bliss GVS Pharma Limited shows a lower P/E and faster revenue growth, while RPG Life Sciences Limited shows a higher ROE, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Bliss GVS Pharma Limited and RPG Life Sciences Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BLISSGVS is more favourable on 5 of 13 scored metrics and RPGLIFE on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
RPGLIFE is the larger company
₹4,948 Cr vs ₹4,782 Cr
P/E Ratio
BLISSGVS has a lower P/E
38.27x vs 43.37x
P/B Ratio
BLISSGVS has a lower P/B
4.14x vs 8.25x
EPS
RPGLIFE has higher earnings per share
₹69.65 vs ₹11.99
Dividend Yield
RPGLIFE has a higher dividend yield
0.75% vs 0.19%
Revenue Growth (TTM YoY)
BLISSGVS has faster revenue growth
29.8% vs 23.6%
EPS Growth (TTM YoY)
BLISSGVS has faster EPS growth
124.7% vs -74.5%
Qtr Sales Growth
RPGLIFE has stronger quarterly sales growth
23.6% vs 13%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLISSGVSRPGLIFE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBLISSGVSRPGLIFE
Live Price₹527.1₹3,001
Day Change0.68%0.1%
Volume3.93 L30,185
52-Week High₹553₹3,082
52-Week Low₹118₹1,733
Distance from 52W High-4.68%-2.63%

Valuation

MetricBLISSGVSRPGLIFE
Market Cap₹4,782 Cr₹4,948 Cr
P/E Ratio38.27x43.37x
P/B Ratio4.14x8.25x
EPS₹11.99₹69.65
Book Value₹107.21₹366.04
Dividend Yield0.19%0.75%

Growth

MetricBLISSGVSRPGLIFE
Revenue Growth (TTM YoY)29.8%23.6%
EPS Growth (TTM YoY)124.7%-74.5%
Qtr Sales Growth13%23.6%
Qtr Profit Growth108%33.7%

Profitability & Leverage

MetricBLISSGVSRPGLIFE
ROE0%19.3%
ROCE11.7%25.7%
Net Margin13.93%29.25%
Operating Margin12.82%20.9%
Debt to Equity1.77x0.03x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricBLISSGVSRPGLIFE
Promoter Holding35.36%72.95%
FII Holding10.45% 4.09 pp0.87% 0.13 pp
DII Holding5.04% 0.74 pp7.45% 0.41 pp
Public Holding49.15% 4.83 pp18.73% 0.28 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Bliss GVS Pharma Limited and RPG Life Sciences Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.